Michelle Kumbier
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Abbott Labs launches Ensure Max Protein as earnings preview approaches. Abbott Laboratories introduced a new high‑protein nutritional drink, Ensure Max Protein, expanding its consumer health lineup. At the same time, investors are looking ahead to the company's third‑quarter earnings, with analysts focusing on revenue and earnings per share estimates. TD Cowen reaffirmed its positive view of Abbott, keeping a $135 price target, which aligns with the analyst consensus range. The stock is currently near a long‑standing support level around $99.90.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Teledyne FLIR Unveils New Counter-Drone Radar at AUSA 2026. Teledyne FLIR Defense introduced the Ranger R10-3DX, a compact mid-range counter-drone radar, during the AUSA 2026 event. This product launch highlights the company's ongoing focus on defense technology solutions. Additionally, Teledyne has announced details for its upcoming third-quarter 2026 earnings webcast, keeping investors informed on future financial reporting.
Transaction History
| RYZ | ▲ Buy | Grant | 97 | $0 | 7/23/2026 | View on chart |
| ABT | ▲ Buy | Grant | 2,286 | $0 | 4/24/2026 | View on chart |
| TDY | ▲ Buy | Grant | 319 | $0 | 4/22/2026 | View on chart |
| RYZ | ▲ Buy | Grant | 389 | $0 | 4/10/2026 | View on chart |
| RYZ | ▲ Buy | Grant | 347 | $0 | 1/1/2026 | View on chart |
| RYZ | ▲ Buy | Grant | 382 | $0 | 9/30/2025 | View on chart |
| RYZ | ▲ Buy | Grant | 405 | $0 | 6/30/2025 | View on chart |
| ABT | ▲ Buy | Grant | 1,635 | $0 | 4/25/2025 | View on chart |
| TDY | ▲ Buy | Grant | 468 | $0 | 4/23/2025 | View on chart |
| RYZ | ▲ Buy | Grant | 381 | $0 | 4/1/2025 | View on chart |
| RYZ | ▲ Buy | Grant | 472 | $0 | 12/31/2024 | View on chart |
| RYZ | ▲ Buy | Grant | 439 | $0 | 10/1/2024 | View on chart |
| RYZ | ▲ Buy | Grant | 330 | $0 | 7/1/2024 | View on chart |
| ABT | ▲ Buy | Grant | 1,866 | $0 | 4/26/2024 | View on chart |
| TDY | ▲ Buy | Grant | 468 | $0 | 4/24/2024 | View on chart |
| ABT | ▲ Buy | Grant | 1,816 | $0 | 4/28/2023 | View on chart |
| TDY | ▲ Buy | Grant | 419 | $0 | 4/26/2023 | View on chart |
| ABT | ▲ Buy | Grant | 1,602 | $0 | 4/29/2022 | View on chart |
| TDY | ▲ Buy | Grant | 376 | $0 | 4/27/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
RYZ to Hold Q3 2026 Earnings Call on Oct 29
Ryerson Holding announced an earnings call for Thursday, October 29, to review its third‑quarter 2026 results. The discussion will provide details on the company's recent performance and outlook. The stock is currently trading near its $23.98 support level, which may draw attention as investors await the update.
RYZ to Hold Q3 2026 Earnings Call on Oct 29. Ryerson Holding announced an earnings call for Thursday, October 29, to review its third‑quarter 2026 results. The discussion will provide details on the company's recent performance and outlook. The stock is currently trading near its $23.98 support level, which may draw attention as investors await the update.